Premium
The cytopathologist's expanding role in the 2018 updated molecular testing guidelines for lung cancer
Author(s) -
Bellevicine Claudio,
Troncone Giancarlo
Publication year - 2018
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.22060
Subject(s) - medicine , lung cancer , cytopathology , molecular pathology , medical physics , cancer , lung cancer screening , pathology , oncology , family medicine , cytology , biochemistry , chemistry , gene
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) International joint committee has recently updated the previous 2013 molecular guidelines version. Here we summarize these changes which demonstrate that molecular cytopathology is here to stay.